Journal of Neuroinflammation, 2022
Immunoadsorption versus double-dose methylprednisolone in refractory multiple sclerosis relapses

Pfeuffer S., Rolfes L., Wirth T. et al.

Journal of the American Society of Nephrology, 2022
Blood Transcriptomes of SARS-CoV-2–Infected Kidney Transplant Recipients Associated with Immune Insufficiency Proportionate to Severity

Sun Z., Zhang Z., Banu K. et al.

JACC: Heart Failure, 2022
Pathophysiologic Processes and Novel Biomarkers Associated With Congestion in Heart Failure

Pandhi P., ter Maaten J., Anker S. et al.

Molecular Psychiatry, 2022
Cerebrospinal fluid proteomic study of two bipolar disorder cohorts

Isgren A., Göteson A., Holmén-Larsson J. et al.

Scientific Reports, 2022
Association of extracellular vesicle inflammatory proteins and mortality

Noren Hooten N., Torres S., Mode N. et al.

Journal of Clinical Immunology, 2022
SOCS1 Haploinsufficiency Presenting as Severe Enthesitis, Bone Marrow Hypocellularity, and Refractory Thrombocytopenia in a Pediatric Patient with Subsequent Response to JAK Inhibition

Michniacki T., Walkovich K., DeMeyer L. et al.

Nature Communications, 2022
ELF5 is a potential respiratory epithelial cell-specific risk gene for severe COVID-19

Pietzner M., Chua R., Wheeler E. et al.

Multiple Sclerosis and Related Disorders, 2022
High-intensity resistance training in people with multiple sclerosis experiencing fatigue: A randomised controlled trial

Englund S., Piehl F., Kierkegaard M.

Nature Cardiovascular Research, 2022
Identification of LTBP-2 as a plasma biomarker for right ventricular dysfunction in human pulmonary arterial hypertension

Boucherat O., Yokokawa T., Krishna V. et al.

PROTEOMICS – Clinical Applications, 2022
Plasma biomarkers for systemic inflammation in COVID‐19 survivors

Zhao J., Schank M., Wang L. et al.

Journal of Investigative Dermatology, 2022
Comparison of the Inflammatory Circuits in Psoriasis Vulgaris, Non‒Pustular Palmoplantar Psoriasis, and Palmoplantar Pustular Psoriasis

Wang C., Haxhinasto S., Garcet S. et al.

Brain Communications, 2022
Neurofilament light increases over time in severe COVID-19 and is associated with delirium

Smeele P., Vermunt L., Blok S. et al.

Clinical Lymphoma Myeloma and Leukemia, 2022
High Dimensional Immune Profiling of Smoldering Multiple Myeloma Distinguishes Distinct Tumor Microenvironments

Fernandez N., Perumal D., Rahman A. et al.

The Lancet Digital Health, 2022
Development of a multiomics model for identification of predictive biomarkers for COVID-19 severity: a retrospective cohort study

Byeon S., Madugundu A., Garapati K. et al.

Cell Systems, 2022
Multi-omics personalized network analyses highlight progressive disruption of central metabolism associated with COVID-19 severity

Ambikan A., Yang H., Krishnan S. et al.

eBioMedicine, 2022
A classification and regression tree analysis identifies subgroups of childhood type 1 diabetes

Achenbach P., Hippich M., Zapardiel-Gonzalo J. et al.

Acta Neuropathologica Communications, 2022
Increased CSF-decorin predicts brain pathological changes driven by Alzheimer’s Aβ amyloidosis

Jiang R., Smailovic U., Haytural H. et al.

Clinical Nutrition, 2022
Proteomics of the phase angle: Results from the population-based KORA S4 study

Huemer M., Petrera A., Hauck S. et al.

Cell Reports Medicine, 2022
Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19

Feyaerts D., Hédou J., Gillard J. et al.

Molecular Metabolism, 2022
Genome-wide association study for circulating FGF21 in patients with alcohol use disorder: Molecular links between the SNHG16 locus and catecholamine metabolism

Ho M., Zhang C., Moon I. et al.